2Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care, 2004, 27(7) :1761-1773.
3Schnedl WJ, Krause R, Halwachs,Baumann G, et al. Evaluation of HbAlc determination methods in patients with hemoglobinopathies. Diabetes Care, 2000, 23 (3) :339-344.
4Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem, 2001,47(2) :153-163.
5American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care, 2001, 24 ( Suppl 1 ) : S1- S133.
6American Diabetes Association. Standards of medical care in diabetes. Diabetes Care, 2004, 27 (Suppl 1) :S15-S35.
7Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycaemic control in Type Ⅰ diabetic pregnancy; results of a nation wide study in The Netherlands. Diabetologia, 2002, 45 ( 11 ) : 1484-1489.
8Kennedy DM, Johnson AB, Hill PG. A comparison of automated fructosamine and HbAlc methods for monitoring diabetes in pregnancy. Ann Clin Biochem, 1998, 35 (Pt 2) : 283 -289.
9Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 36) : prospective observational study. BMJ, 2000, 321(7258) :412-419.
10Krishnamurti U, Steffes MW. Glycohemoglobin:a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem, 2001,47 (7) : 1157-1165.